SCHEMBL4688573

SCHEMBL4688573

O=C(O)COc1ccc2c(c1[N+](=O)[O-])C(=O)CC2

nearest known ligand 0.42

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
PTGDR2 Q9Y5Y4 3/20 0.42
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
ACMSD Q8TDX5 1/20 0.39
HPD P32754 7/20 0.38
ALOX15 P16050 1/20 0.37
TSHR P16473 1/20 0.37
HSD17B10 Q99714 1/20 0.37
TDP1 Q9NUW8 1/20 0.35
CYP2C19 P33261 1/20 0.35
ALDH1A1 P00352 1/20 0.35
POLB P06746 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
CD69 Q07108 1/20 0.34
GLA P06280 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4688521 0.79 KDM4E (0.49) MEN1KMT2ATDP1ALDH1A1POLB
SCHEMBL4684709 0.78 PTGDR2 (0.40) PTGDR2ALOX15TSHRHSD17B10TDP1
SCHEMBL8558154 0.77 SMN1; SMN2 (0.39) PTGDR2MEN1KMT2AHPDTDP1
SCHEMBL8558148 0.77 SMN1; SMN2 (0.39) PTGDR2MEN1KMT2AHPDTDP1
SCHEMBL4686035 0.72 GPR35 (0.41) KMT2AALOX15TSHRHSD17B10ALDH1A1
SCHEMBL12992926 0.71 ALDH1A1 (0.42) MEN1KMT2AHPDTDP1CYP2C19
SCHEMBL214122 0.69 ALDH1A1 (0.56) PTGDR2MEN1KMT2ATSHRTDP1
SCHEMBL6998270 0.67 MEN1 (0.43) MEN1KMT2AHPDALOX15TSHR
SCHEMBL11030777 0.67 TSHR (0.52) PTGDR2MEN1KMT2AALOX15TSHR
SCHEMBL19869338 0.66 ALDH1A1 (0.39) KMT2AALOX15TSHRHSD17B10TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0885210-B2 Tricylic compounds having binding affinity for melatonin receptors, their production and use TAKEDA PHARMACEUTICAL (JP) 2008-06-18 EP disclosed
EP-1550655-A1 Bicyclic intermediates Takeda Pharmaceutical Company Limited (JP) 2005-07-06 EP disclosed
EP-0885210-B1 Tricylic compounds having binding affinity for melatonin receptors, their production and use TAKEDA CHEMICAL INDUSTRIES LTD (JP) 2002-06-12 EP disclosed
EP-1199304-A1 Bicyclic compounds and pharmaceutical composition containing tricyclic compound for treating or preventing sleep disorders Takeda Chemical Industries, Ltd. (JP) 2002-04-24 EP disclosed
US-6218429-B1 TREATING MELATONIN RELATED DISORDERS (E.G. CIRCARDIAN RHYTHMS, SLEEP-AWAKE CYCLES, TIME ZONE CHANGES, SLEEP DISORDERS) TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2001-04-17 US disclosed
US-6034239-A BINDIG TO MELATONIN RECEPTORS; SLEEP DISORDERS; GLANDULAR DISORDERS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2000-03-07 US disclosed